Skip to main content

Table 5 Summary of diagnostic performance of Oncuria™ in high-grade/low-grade and high stage/low stage bladder cancer

From: Diagnostic performance of Oncuria™, a urinalysis test for bladder cancer

  Number of bladder cancer cases predicted by biomarker assay AUC Sensitivity (%) Specificity (%) NPV (%) PPV (%)
Overall 42/45a 0.95 0.93 0.93 0.99 0.65
Low-grade tumors 8/9 0.94 0.89 0.93 1.00 0.26
High-grade tumors 34/36 0.95 0.94 0.93 1.00 0.60
NMIBC 25/27 0.93 0.93 0.93 0.99 0.52
MIBC 15/16 0.97 0.94 0.93 1.00 0.39
  1. NMIBC non-muscle invasive bladder cancer, MIBC muscle invasive bladder cancer, AUC Area under ROC curve;
  2. a1 missing an analyte and thus excluded